Form D · Biotechnology
MEDAFOR INC
Minneapolis, MN · CIK 0001104922
Offering snapshot reported Sep 27, 2012 · SEC filing
- Reported sold
- $15K Offering amount: $15K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 14, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 27, 2012 | Initial | $15,000 | No comparison | 2 | SEC filing |
| Sep 8, 2009 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Dec 18, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 9, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 31, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 7, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-184711
Source: Form D, filed Sep 27, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kraig C. Black | Executive |
| Jon Freeman | Executive |
| Paul A. Gray | Director |
| Robert L. Halverson | Director |
| Michael F. Pasquale | Director |
| Gary J. Shope | Director, Executive |
| Gavin J. Thomson | Executive |
| Gerald D. Van Eeckhout | Director |
| Dr. Craig B. Wisman | Executive |
| Craig D. Wismann, Md Mmm | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2700 Fredway Boulevard Suite 800
Minneapolis, MN, 55430
Minneapolis, MN, 55430